99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution

This publication has 10 references indexed in Scilit:

• ^99mTc Labeling of Highly Potent Small Peptides
  Bioconjugate Chemistry, 1997
• New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc
  Bioconjugate Chemistry, 1997
• Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc
  Bioconjugate Chemistry, 1997
• Radiolabeled somatostatin analogs in prostate cancer
  Nuclear Medicine and Biology, 1997
• Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with ^99mTc Using Aminocarboxylates as Coligands
  Bioconjugate Chemistry, 1996
• Radiolabelled peptides
  Nuclear Medicine Communications, 1995
• [99mTc]Tricine: a Useful Precursor Complex for the Radiolabeling of Hydrazinonicotinate Protein Conjugates
  Bioconjugate Chemistry, 1995
• Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides
  Nuclear Medicine and Biology, 1995
• Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors
  New England Journal of Medicine, 1994
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993